CD8A and neoplasm: The study employed single-cell RNA sequencing and flow cytometry to analyze immune cell changes, revealing that WBM reduces PMN-MDSCs and boosts cytotoxic CD8+ T-cell and NK cell activity, slowing tumor progression [47].